Additionally, MET, TGFα, FGF2, CD151, and MMP3 are some of the oncogenic targets of miR-152 in human cancers; by targeting these genes, miR-152 leads to inhibition of cell proliferation and tumor metastasis (12). This evidence concerns the gene MET and cancer.